Biodefense Market 2018
Wiseguyreports.Com adds “Biodefense Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2025” To Its Research Database.Report Details:
This report provides in depth study of “Biodefense Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Biodefense Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.
The global Biodefense market is valued at 850 million US$ in 2017 and will reach 1500 million US$ by the end of 2025, growing at a CAGR of 7.3% during 2018-2025.
This report studies the global Biodefense market status and forecast, categorizes the global Biodefense market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.
Biodefense market refers to the pharmaceuticals, vaccines and antibodies applied in the treatment of a wide range of infectious diseases, whether those diseases emerge naturally or are deliberately introduced as an act of bioterrorism. Biodefense products generally defense against anthrax, smallpox, botulism, radiation/nuclear disasters and other disasters.
In the wake of the 2001 anthrax attacks, the U.S. government set out on a bold path to improve the country’s preparedness for bioterrorism by developing and stockpiling new drugs and vaccines to protect Americans from health emergencies. Since 2004, the US government has provided assistance in the development and manufacturing of products in order to maintain its Strategic National Stockpile (SNS) to counter any bioterror attack.
USA is still the largest supplier and consumption market due to the highly developed pharmaceuticals technology and increased awareness of the threat of global terror activity. In 2015, USA enjoyed over 80% consumption market.
By type, Anthrax defense products are most used with market share over 40%, followed by Smallpox defense products and Botulism defense products separately with market share about 30% and 14%. In addition, other diseases like Ebola and Marburg are occupying more and more market share.
In this year, the international situation is not complex, and partial conflict is frequent. Terrorist organization like IS was just making terrorist activity in Paris, which largely increased people’s awareness of the threat of terrorist activity. As a result, the biodefense industry is expecting in the next years.
The major manufacturers covered in this report
Emergent Biosolutions
Hytest
GSK
Sanofi
PharmAthene
Bavarian Nordic
SIGA Technologies
Arbutus Biopharma
DynPort Vaccine
Xoma Corporation
Ichor Medical Systems
Aeolus Pharmaceuticals
Achaogen
Elusys Therapeutics
Dynavax Technologies
Cleveland BioLabs
Soligenix
Alnylam Pharmaceuticals
Request a Sample Report @ https://www.wiseguyreports.com/sample-request/3217956-global-biodefense-market-research-report-2018
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
North America
Europe
China
Japan
Southeast Asia
India
We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Anthrax
Smallpox
Botulism
Radiation/Nuclear
Others
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
US Military Market
US Civilian Market
Non - US Market
Key Stakeholders
Biodefense Manufacturers
Biodefense Distributors/Traders/Wholesalers
Biodefense Subcomponent Manufacturers
Industry Association
Downstream Vendors
If you have any special requirements, please let us know and we will offer you the report as you want.
Complete Report Details@ https://www.wiseguyreports.com/reports/3217956-global-biodefense-market-research-report-2018
Major Key Points in Table of Content:
Global Biodefense Market Research Report 2018
1 Biodefense Market Overview
1.1 Product Overview and Scope of Biodefense
1.2 Biodefense Segment by Type (Product Category)
1.2.1 Global Biodefense Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Biodefense Production Market Share by Type (Product Category) in 2017
1.2.3 Anthrax
1.2.4 Smallpox
1.2.5 Botulism
1.2.6 Radiation/Nuclear
1.2.7 Others
1.3 Global Biodefense Segment by Application
1.3.1 Biodefense Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 US Military Market
1.3.3 US Civilian Market
1.3.4 Non - US Market
1.4 Global Biodefense Market by Region (2013-2025)
1.4.1 Global Biodefense Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 Southeast Asia Status and Prospect (2013-2025)
1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Biodefense (2013-2025)
1.5.1 Global Biodefense Revenue Status and Outlook (2013-2025)
1.5.2 Global Biodefense Capacity, Production Status and Outlook (2013-2025)
….
7 Global Biodefense Manufacturers Profiles/Analysis
7.1 Emergent Biosolutions
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Biodefense Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Emergent Biosolutions Biodefense Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 Hytest
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Biodefense Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Hytest Biodefense Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 GSK
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Biodefense Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 GSK Biodefense Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
7.4 Sanofi
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Biodefense Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Sanofi Biodefense Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.4.4 Main Business/Business Overview
7.5 PharmAthene
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Biodefense Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 PharmAthene Biodefense Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
7.5.4 Main Business/Business Overview
Continued….
Contact Us:
NORAH TRENT
Ph: +1-646-845-9349 (US)
Sales@Wiseguyreports.Com
Ph: +44 208 133 9349 (UK)
No comments:
Post a Comment